Ya Lei

No ORCID on file · 4 papers in corpus · active 2023

Study types

  • article 3
  • preprint 1

Condition tags

  • endometriosis 2
  • adenomyosis 2
  • dysmenorrhea 1
article 2023
An insight into gut microbiota and metabolites in the mice with adenomyosis
Frontiers in cellular and infection microbiology ·doi:10.3389/fcimb.2023.1075387

Background Adenomyosis (AM) is a benign uterine disease characterized pathologically by the invasion of endometrial tissue into the myometrium. The pathogenesis of AM is still far from clear. Although the gut microbiome and metabolomics are…

article 2023
Dahuang—Taoren, a botanical drug combination, ameliorates adenomyosis via inhibiting Rho GTPases
Frontiers in pharmacology ·doi:10.3389/fphar.2023.1089004

Introduction: Dahuang-Taoren (DT) is a classic combination of botanical drugs applied to treat pain-related diseases in ancient China. Today, DT is frequently applied for dysmenorrhea of adenomyosis (AM) in the clinic. Growing evidence indi…

article 2023
Network pharmacology prediction and experimental verification of Rhubarb-Peach Kernel promoting apoptosis in endometriosis
BMC complementary medicine and therapies ·doi:10.1186/s12906-023-04084-8

BACKGROUND: "Rhubarb-Peach Kernel" herb pair (RP) one of the most frequently used drug pairs, has been used in traditional medicine in China to treat inflammation and diseases associated with pain. Although it is widely used clinically and …

preprint 2023
Network Pharmacology Prediction and Experimental Verification of Rhubarb-Peach Kernel Promoting Apoptosis in Endometriosis
·doi:10.21203/rs.3.rs-2720763/v1

Abstract Background " Rhubarb-Peach Kernel " herb pair (RP) one of the most frequently used drug pairs, has been used in traditional medicine in China to treat inflammation and diseases associated with pain. Although it is widely used clini…